| 标题 |
Abstract 579: A novel nanobody-based radionuclide drug conjugate (RDC) platform through introducing a human serum albumin (HSA) binder by the intelligent ligase-dependent conjugation (iLDC) technology: an innovative and versatile approach for next-generation RDCs with enhanced pharmacokinetics and druggability |
| 网址 | |
| DOI |
10.1158/1538-7445.am2025-579
doi
|
| 其它 |
期刊:Cancer Research 作者:Chun‐Feng Liu; Sipeng Li; Zengyan Mu; Yajun Sun; Haibo He; et al 出版日期:2025-04-21 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)